Please login to the form below

Not currently logged in
Email:
Password:

NanoValent promotes Mark Lewis to COO

He will also continue to manage the group’s business operations

NanoValent Mark LewisUK and US-based NanoValent Pharmaceuticals has promoted Mark Lewis to chief operating officer.

Lewis brings over 30 years of international commercial and operations expertise - gained primarily in the area of oncology - to the role, and first joined the early-stage oncology group in 2015.

He has worked at a number of pharmaceutical firms including Amersham International (now GE), Chiron (now Novartis) and Farmitalia (now Pfizer).

In addition to his pharmaceutical experience, Lewis also spent 10 years as a management consultant, working at Hill & Knowlton and Quintiles.

Most recently, Lewis served as managing director for Europe at SuperGen (now Otsuka Pharmaceutical) between 2006 and 2010, and was senior vice president of Ascalon Inc from 2010 until 2012.

8th August 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics